Gilead, manufacturer of the TROP2-directed antibody-drug conjugate sacituzumab govitecan, made the decision to withdraw the ...

Gilead is withdrawing the accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for metastatic urothelial cancer.

Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on GILD stock, giving a Buy rating today. Tyler Van Buren’s rating ...

Inside the Last-Ditch Hunt by Harris and Trump for Undecided Voters Both campaigns think many of these crucial Americans are younger, Black or Latino. The Harris team is also eyeing white, college ...

With two weeks to go before the U.S. presidential election, cases of political violence have shown the biggest and most sustained increase since the 1970s. United Statescategory Nebraska ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

His attendance at a Russian conference is a shocking step backwards less than three years since the UN condemned Moscow’s brutal invasion ...